Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Pharmaceuticals

Carbohydrate Vaccines

Novel chemical and enzymatic oligosaccharide synthesis techniques could lead to a new generation of carbohydrate-based vaccine agents

by STU BORMAN, C&EN WASHINGTON
August 9, 2004 | A version of this story appeared in Volume 82, Issue 32

Article:

This article has been sent to the following recipient: